Page last updated: 2024-09-03

1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene and Liver Neoplasms

1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene has been researched along with Liver Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braeuning, A; Dusek, J; Hirsova, P; Holas, O; Horvatova, A; Kucera, O; Linhartova, L; Micuda, S; Pavek, P; Skoda, J; Smutny, T1
Baer-Dubowska, W; Cichocki, M; Jodynis-Liebert, J; Murias, M; Wierzchowski, M1

Other Studies

2 other study(ies) available for 1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene and Liver Neoplasms

ArticleYear
Stilbene compound trans-3,4,5,4´-tetramethoxystilbene, a potential anticancer drug, regulates constitutive androstane receptor (Car) target genes, but does not possess proliferative activity in mouse liver.
    Toxicology letters, 2019, Oct-01, Volume: 313

    Topics: Animals; Anticarcinogenic Agents; Apoptosis; Aryl Hydrocarbon Hydroxylases; Binding Sites; Cell Proliferation; Constitutive Androstane Receptor; Cytochrome P450 Family 2; Gene Expression Regulation, Enzymologic; Gluconeogenesis; Hep G2 Cells; Hepatocytes; Humans; Lipogenesis; Liver; Liver Neoplasms; Male; Mice, Inbred C57BL; Molecular Docking Simulation; Protein Binding; Pyridines; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Steroid Hydroxylases; Stilbenes

2019
3,4,5,4'-trans-tetramethoxystilbene (DMU-212) modulates the activation of NF-κB, AP-1, and STAT3 transcription factors in rat liver carcinogenesis induced by initiation-promotion regimen.
    Molecular and cellular biochemistry, 2014, Volume: 391, Issue:1-2

    Topics: Animals; Carcinogenesis; Cyclooxygenase 2; I-kappa B Proteins; Liver; Liver Neoplasms; Male; NF-kappa B; Nitric Oxide Synthase Type II; Rats, Wistar; STAT3 Transcription Factor; Stilbenes; Transcription Factor AP-1

2014